• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硫胺素增强毒蕈碱M4受体处乙酰胆碱的亲和力:通过协同作用而非亲和力实现受体亚型选择性。

Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity.

作者信息

Lazareno S, Dolezal V, Popham A, Birdsall N J M

机构信息

MRC Technology, Mill Hill, London NW7 1AD, United Kingdom.

出版信息

Mol Pharmacol. 2004 Jan;65(1):257-66. doi: 10.1124/mol.65.1.257.

DOI:10.1124/mol.65.1.257
PMID:14722259
Abstract

Thiochrome (2,7-dimethyl-5H-thiachromine-8-ethanol), an oxidation product and metabolite of thiamine, has little effect on the equilibrium binding of l-[3H]N-methyl scopolamine ([3H]NMS) to the five human muscarinic receptor subtypes (M1-M5) at concentrations up to 0.3 mM. In contrast, it inhibits [3H]NMS dissociation from M1 to M4 receptors at submillimolar concentrations and from M5 receptors at 1 mM. These results suggest that thiochrome binds allosterically to muscarinic receptors and has approximately neutral cooperativity with [3H]NMS at M1 to M4 and possibly M5 receptors. Thiochrome increases the affinity of acetylcholine (ACh) 3- to 5-fold for inhibiting [3H]NMS binding to M4 receptors but has no effect on ACh affinity at M1 to M3 or M5 receptors. Thiochrome (0.1 mM) also increases the direct binding of [3H]ACh to M4 receptors but decreases it slightly at M2 receptors. In agreement with the binding data, thiochrome does not affect the potency of ACh for stimulating the binding of guanosine 5'-O-(3-[35S]thiotriphosphate) ([35S]GTPgammaS) to membranes containing M1 to M3 receptors, but it increases ACh potency 3.5-fold at M4 receptors. It also selectively reduces the release of [3H]ACh from potassium-stimulated slices of rat striatum, which contain autoinhibitory presynaptic M4 receptors, but not from hippocampal slices, which contain presynaptic M2 receptors. We conclude that thiochrome is a selective M4 muscarinic receptor enhancer of ACh affinity and has neutral cooperativity with ACh at M1 to M3 receptors; it therefore demonstrates a powerful new form of selectivity, "absolute subtype selectivity", which is derived from cooperativity rather than from affinity.

摘要

硫色素(2,7-二甲基-5H-硫代色满-8-乙醇)是硫胺素的氧化产物和代谢物,在浓度高达0.3 mM时,对l-[3H]N-甲基东莨菪碱([3H]NMS)与五种人类毒蕈碱受体亚型(M1-M5)的平衡结合几乎没有影响。相比之下,它在亚毫摩尔浓度下抑制[3H]NMS从M1到M4受体的解离,在1 mM时抑制[3H]NMS从M5受体的解离。这些结果表明硫色素与毒蕈碱受体变构结合,在M1到M4以及可能的M5受体上与[3H]NMS具有近似中性的协同性。硫色素使乙酰胆碱(ACh)抑制[3H]NMS与M4受体结合的亲和力提高3至5倍,但对M1到M3或M5受体的ACh亲和力没有影响。硫色素(0.1 mM)还增加[3H]ACh与M4受体的直接结合,但在M2受体处略有降低。与结合数据一致,硫色素不影响ACh刺激鸟苷5'-O-(3-[35S]硫代三磷酸)([35S]GTPγS)与含有M1到M3受体的膜结合的效力,但它使ACh在M4受体处的效力提高3.5倍。它还选择性地减少了来自含有自身抑制性突触前M4受体的大鼠纹状体钾刺激切片中[3H]ACh的释放,但不减少来自含有突触前M2受体的海马切片中[3H]ACh的释放。我们得出结论,硫色素是ACh亲和力的选择性M4毒蕈碱受体增强剂,在M1到M3受体上与ACh具有中性协同性;因此,它展示了一种强大的新型选择性,即“绝对亚型选择性”,这种选择性源自协同性而非亲和力。

相似文献

1
Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity.硫胺素增强毒蕈碱M4受体处乙酰胆碱的亲和力:通过协同作用而非亲和力实现受体亚型选择性。
Mol Pharmacol. 2004 Jan;65(1):257-66. doi: 10.1124/mol.65.1.257.
2
Allosteric effects of four stereoisomers of a fused indole ring system with 3H-N-methylscopolamine and acetylcholine at M1-M4 muscarinic receptors.具有3H-N-甲基东莨菪碱和乙酰胆碱的稠合吲哚环系统的四种立体异构体在M1-M4毒蕈碱受体上的变构效应。
Life Sci. 1999;64(6-7):519-26. doi: 10.1016/s0024-3205(98)00596-7.
3
Subtype-selective positive cooperative interactions between brucine analogs and acetylcholine at muscarinic receptors: functional studies.马钱子碱类似物与毒蕈碱受体处乙酰胆碱之间的亚型选择性正协同相互作用:功能研究
Mol Pharmacol. 1999 Apr;55(4):778-86.
4
Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.阿库氯铵对克隆的M1 - M5毒蕈碱型乙酰胆碱受体正向变构作用的亚型选择性。
J Pharmacol Exp Ther. 1995 Sep;274(3):1077-83.
5
Divergence of allosteric effects of rapacuronium on binding and function of muscarinic receptors.瑞帕库铵对毒蕈碱受体结合及功能变构效应的差异
BMC Pharmacol. 2009 Dec 28;9:15. doi: 10.1186/1471-2210-9-15.
6
Subtype-selective positive cooperative interactions between brucine analogues and acetylcholine at muscarinic receptors: radioligand binding studies.马钱子碱类似物与毒蕈碱受体上的乙酰胆碱之间的亚型选择性正协同相互作用:放射性配体结合研究
Mol Pharmacol. 1998 Mar;53(3):573-89. doi: 10.1124/mol.53.3.573.
7
Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells.神经肌肉阻断药物与在中国仓鼠卵巢细胞中表达的重组人毒蕈碱型m1 - m5受体的相互作用。
Br J Pharmacol. 1998 Nov;125(5):1088-94. doi: 10.1038/sj.bjp.0702166.
8
Selective labeling and localization of the M4 (m4) muscarinic receptor subtype.M4(m4)毒蕈碱受体亚型的选择性标记与定位
Mol Pharmacol. 1994 Dec;46(6):1028-35.
9
Stereoselective recognition of the enantiomers of phenglutarimide and of six related compounds by four muscarinic receptor subtypes.四种毒蕈碱受体亚型对苯戊二酰亚胺对映体及六种相关化合物的立体选择性识别。
Br J Pharmacol. 1996 Dec;119(7):1319-30. doi: 10.1111/j.1476-5381.1996.tb16041.x.
10
Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors.毒蕈碱毒素3在克隆受体和天然受体功能测定中的选择性概况。
J Pharmacol Exp Ther. 1999 Jan;288(1):164-70.

引用本文的文献

1
Discovery of Non-Peptide GLP-1 Positive Allosteric Modulators from Natural Products: Virtual Screening, Molecular Dynamics, ADMET Profiling, Repurposing, and Chemical Scaffolds Identification.从天然产物中发现非肽类胰高血糖素样肽-1(GLP-1)正变构调节剂:虚拟筛选、分子动力学、药物代谢动力学/药物毒性预测、药物再利用及化学骨架鉴定
Pharmaceutics. 2024 Dec 17;16(12):1607. doi: 10.3390/pharmaceutics16121607.
2
[Not Available].[不可用]。
Acta Pharm Sin B. 2024 Jan;14(1):67-86. doi: 10.1016/j.apsb.2023.07.020. Epub 2023 Jul 21.
3
Allosteric modulation of G protein-coupled receptor signaling.
变构调节 G 蛋白偶联受体信号转导。
Front Endocrinol (Lausanne). 2023 Feb 16;14:1137604. doi: 10.3389/fendo.2023.1137604. eCollection 2023.
4
Allosteric Modulation of Muscarinic Receptors by Cholesterol, Neurosteroids and Neuroactive Steroids.胆固醇、神经甾体和神经活性甾体对毒蕈碱受体的变构调节。
Int J Mol Sci. 2022 Oct 28;23(21):13075. doi: 10.3390/ijms232113075.
5
Drug Design Targeting the Muscarinic Receptors and the Implications in Central Nervous System Disorders.靶向毒蕈碱受体的药物设计及其对中枢神经系统疾病的影响
Biomedicines. 2022 Feb 7;10(2):398. doi: 10.3390/biomedicines10020398.
6
Non-peptide agonists and positive allosteric modulators of glucagon-like peptide-1 receptors: Alternative approaches for treatment of Type 2 diabetes.胰高血糖素样肽-1 受体的非肽类激动剂和正变构调节剂:治疗 2 型糖尿病的替代方法。
Br J Pharmacol. 2022 Feb;179(4):511-525. doi: 10.1111/bph.15446. Epub 2021 Apr 19.
7
Novel Positive Allosteric Modulators of µ Opioid Receptor-Insight from In Silico and In Vivo Studies.新型μ阿片受体正变构调节剂:基于计算机模拟和体内研究的见解。
Int J Mol Sci. 2020 Nov 11;21(22):8463. doi: 10.3390/ijms21228463.
8
Structural Modeling and in Silico Screening of Potential Small-Molecule Allosteric Agonists of a Glucagon-like Peptide 1 Receptor.胰高血糖素样肽-1受体潜在小分子变构激动剂的结构建模与计算机筛选
ACS Omega. 2019 Jan 11;4(1):961-970. doi: 10.1021/acsomega.8b03052. eCollection 2019 Jan 31.
9
Utilization of Biased G Protein-Coupled ReceptorSignaling towards Development of Safer andPersonalized Therapeutics.利用偏向的 G 蛋白偶联受体信号转导开发更安全和个体化的治疗药物。
Molecules. 2019 May 29;24(11):2052. doi: 10.3390/molecules24112052.
10
Designing Hybrids Targeting the Cholinergic System by Modulating the Muscarinic and Nicotinic Receptors: A Concept to Treat Alzheimer's Disease.设计针对胆碱能系统的杂种分子:通过调节毒蕈碱和烟碱受体来治疗阿尔茨海默病的一种概念。
Molecules. 2018 Dec 7;23(12):3230. doi: 10.3390/molecules23123230.